Stephanie Guerrera

Stephanie Guerrera has extensive work experience in the biotech industry. Stephanie served as the Vice President, Project Leader, and PMO Head at Repare Therapeutics from August 2019 onwards. Prior to this, from October 2018 to July 2020, they worked as the President & CEO of IPM (Innovative Project Management) Consulting, LLC, where they provided project leadership and management consulting services to small biotech companies. Stephanie also worked at GlaxoSmithKline for a long period, starting in October 1996. During their time there, they held roles such as Project Director and Project Leader Oncology, showcasing their expertise in the field.

Stephanie Guerrera's education history begins in 1983 when they attended Lafayette College. However, it is not specified if they obtained a degree or the field of study during their time there.

Stephanie later enrolled in Hahnemann Medical College for a Master's degree in Molecular Biology, although the specific duration of this program is not provided.

In 1992, Stephanie pursued a Master of Science (MS) in Molecular Biology at Drexel University, completing their studies in 1997.

Stephanie then pursued an MBA in Pharmaceutical Marketing at Saint Joseph's University from 2002 to 2004. Additionally, during the same period, they also attended the Erivan K. Haub School of Business at Saint Joseph's University, where they obtained a Master of Business Studies (MBS) degree in Pharmaceutical Marketing.

Overall, Stephanie's education encompasses studies in Molecular Biology and Pharmaceutical Marketing from various institutions, spanning from Lafayette College in the 1980s to Saint Joseph's University in the early 2000s.